(SAN JOSE, CA, USA – March 1st, 2021) OmniTier announced today that its CompStor® family now supports mitochondrial analysis in both its secondary and tertiary analysis appliances. Accurate identification of the mitochondrial genome are key requirements for researchers and clinicians seeking to improve their understanding of mitochondrial dysfunction.
Stop by and visit the OmniTier exhibition stand. There you will be able to watch demonstrations of OmniTier’s genomics secondary-analysis and tertiary-analysis appliances. On-premise genomics analysis provide fast, secure results through CompStor's proprietary AI and acceleration technology, at a much lower and predictable cost than cloud based analysis and storage alternatives.
OmniTier today announced that its genomic secondary analysis appliance, CompStor Novos®, has added somatic variant calling from matched, whole genome sequencing (WGS) tumor-normal sample pairs.
Tiered-Memory accelerated High Performance Computing and Storage Solutions for the Life Sciences and Low Latency Edge Applications.